Outer-membrane-vesicle vaccines: Old but not forgotten

The Lancet Infectious Diseases

Volumn 11, Issue 6, 2011, Pages 421-422

  Stephens, David S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOOLIGOSACCHARIDE; MENINGOCOCCUS VACCINE; NERVE CELL ADHESION MOLECULE; OUTER MEMBRANE VESICLE VACCINE; POLYSIALIC ACID; PORIN A; UNCLASSIFIED DRUG;

AUTOIMMUNITY; BACTERIAL STRAIN; EPIDEMIC; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; LETTER; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; DISEASE OUTBREAKS; HUMANS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP B;

EID: 79956262138     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70096-2     Document Type: Letter

References (7)

1. Caron F, Parent du Châtelet I, Leroy J-P, et al. From tailor-made to ready-to-wear meningococcal B vaccines: a longitudinal study of a clonal meningococcal B outbreak. Lancet Infect Dis 2011, Published Online April 12. 10.1016/S1473-3099(11)70027-5.
2. Branham S Serological relationships among meningococci. Bacteriol Rev 1953, 17:175-188.
3. Caugant DA Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998, 106:505-525.
4. Stephens DS, Greenwood B, Brandtzaeg P Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007, 369:2196-2210.
5. Holst J, Martin D, Arnold R, et al. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 2009, 27(suppl 2):B3-12.
6. Elias J, Schouls LM, van de Pol I, et al. Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany. Emerg Infect Dis 2010, 16:465-472.
7. Wedege E, Bolstad K, Aase A, et al. Functional and specific antibody responses in adult volunteers in New Zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines. Clin Vaccine Immunol 2007, 14:830-838.